Omniscient Neurotechnology (o8t)

Omniscient Neurotechnology Pty Ltd (o8t) is an Australian company focused on advanced brain mapping and connectomics technology to enhance neurological care. Their mission is to improve lives by utilizing brain network data for personalized insights, aiding in diagnosis, treatment, and surgical planning for complex neurological conditions. The company develops AI-powered software solutions, including their flagship platform, Quicktome™, which automates the analysis of brain network data from MRI and resting-state functional MRI (rs-fMRI). Quicktome™ generates detailed, patient-specific maps of brain connectivity, enabling clinicians such as neurosurgeons and neurologists to gain a deeper understanding of brain function and structure. The platform supports clinical decision-making across various neurological conditions, including cranial surgery and stroke care. Omniscient Neurotechnology has received regulatory clearances for its Quicktome platform in the United States, Canada, and Australia, highlighting its readiness for clinical use. The company serves medical professionals and researchers, providing advanced brain mapping solutions that facilitate personalized treatment strategies and improve patient outcomes. Based in Sydney, o8t is recognized as a leader in the field of connectomics and brain network analysis.

• Employees 55
• Founded 2019
• Total Funding $29922157